The Spanish Association of Patients Affected by Lymphoma, Myeloma and Leukaemia (AEAL) and Gilead Sciences have renewed and updated their collaboration in the patient support program 'Next to you', aimed at patients who are candidates for CAR-T therapies and who require help to guarantee their access and support during the care process.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The Spanish Association of Patients Affected by Lymphoma, Myeloma and Leukaemia (AEAL) and Gilead Sciences have renewed and updated their collaboration in the patient support program 'Next to you', aimed at patients who are candidates for CAR-T therapies and who require help to guarantee their access and support during the care process.